Last: | $3 |
---|---|
Change Percent: | -1.4% |
Open: | $3.0419 |
Close: | $3 |
High: | $3.0499 |
Low: | $3 |
Volume: | 3,152 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3 | $3.0419 | $3 | $3.0499 | $3 | 3,152 | 03-27-2024 |
$3 | $3.074 | $3 | $3.074 | $2.9 | 2,719 | 03-26-2024 |
$3.0499 | $2.92 | $3.0499 | $3.0499 | $2.92 | 4,269 | 03-25-2024 |
$2.96 | $2.99 | $2.96 | $3.045 | $2.9 | 14,941 | 03-22-2024 |
$3 | $2.94 | $3 | $3.06 | $2.9143 | 11,727 | 03-21-2024 |
$2.94 | $2.97 | $2.94 | $2.9904 | $2.9 | 10,095 | 03-20-2024 |
$2.95 | $2.965 | $2.95 | $3.13 | $2.95 | 18,670 | 03-19-2024 |
$2.97 | $2.9501 | $2.97 | $3 | $2.947 | 3,798 | 03-18-2024 |
$2.96 | $2.96 | $2.96 | $3.16 | $2.95 | 24,036 | 03-15-2024 |
$2.92 | $2.98 | $2.92 | $3.01 | $2.895 | 27,298 | 03-14-2024 |
$3.01 | $3.174 | $3.01 | $3.174 | $2.941 | 18,972 | 03-13-2024 |
$2.98 | $2.94 | $2.98 | $3.05 | $2.94 | 12,977 | 03-12-2024 |
$2.98 | $2.99 | $2.98 | $3.29 | $2.97 | 19,285 | 03-11-2024 |
$3 | $3.03 | $3 | $3.26 | $2.99 | 16,028 | 03-08-2024 |
$2.98 | $3.03 | $2.98 | $3.03 | $2.9107 | 8,139 | 03-07-2024 |
$2.99 | $3.1837 | $2.99 | $3.1837 | $2.8633 | 22,601 | 03-06-2024 |
$3.05 | $3.08 | $3.05 | $3.09 | $2.98 | 986 | 03-05-2024 |
$3.1 | $3.03 | $3.1 | $3.2 | $3.01 | 13,108 | 03-04-2024 |
$3.12 | $3.16 | $3.12 | $3.16 | $2.99 | 11,849 | 03-01-2024 |
$3.1646 | $3.06 | $3.1646 | $3.2696 | $3.04 | 15,545 | 02-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Psychemedics Corporation Company Name:
PMD Stock Symbol:
NASDAQ Market:
Psychemedics Corporation Website:
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR. This prestigious accolade highligh...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...